Your browser doesn't support javascript.
loading
A novel defined TLR3 agonist as an effective vaccine adjuvant.
Ko, Kwang Hyun; Cha, Seung Bin; Lee, Seung-Hwan; Bae, Hyun Shik; Ham, Chul Soo; Lee, Min-Gyu; Kim, Dong-Ho; Han, Seung Hyun.
Afiliação
  • Ko KH; Research and Development Center, NA Vaccine Institute, Seoul, Republic of Korea.
  • Cha SB; Interdisciplinary Program in Genetic Engineering, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea.
  • Lee SH; Research and Development Center, NA Vaccine Institute, Seoul, Republic of Korea.
  • Bae HS; Research and Development Center, NA Vaccine Institute, Seoul, Republic of Korea.
  • Ham CS; Research and Development Center, NA Vaccine Institute, Seoul, Republic of Korea.
  • Lee MG; Research and Development Center, NA Vaccine Institute, Seoul, Republic of Korea.
  • Kim DH; Research and Development Center, NA Vaccine Institute, Seoul, Republic of Korea.
  • Han SH; Research and Development Center, NA Vaccine Institute, Seoul, Republic of Korea.
Front Immunol ; 14: 1075291, 2023.
Article em En | MEDLINE | ID: mdl-36761735
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Receptor 3 Toll-Like / Adjuvantes de Vacinas Limite: Animals Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Receptor 3 Toll-Like / Adjuvantes de Vacinas Limite: Animals Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de publicação: Suíça